經臨床研究證實副乾酪乳桿菌 PS23 對抗肌肉減少症有效
2022年11月2日
讀畢需時 1 分鐘
2 November 2022 | By Nikki Hancocks

A new randomised clinical trial of a medical food composed of omega-3, leucine, and probiotic Lactobacillus paracasei PS23 has concluded that this could be considered as a treatment for sarcopenia in the elderly.
Learn more at:



留言